MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$236,577K
Cash and cash
equivalents
$30,309K
Prepaid expenses and
other current assets
$6,407K
Total current assets
$273,293K
Property and equipment,
net
$70,023K
Operating lease
right-of-use asset
$38,819K
Restricted cash
$10,292K
Other long-term
assets
$3,531K
Total assets
$395,958K
Total liabilities and
stockholders equity
$395,958K
Total stockholders
equity
$278,875K
Total liabilities
$117,083K
Accumulated deficit
-$2,053,316K
Accumulated other
comprehensive income (loss)
-$183K
Additional paid-in capital
$2,332,129K
Lease liability,
noncurrent
$72,633K
Total current
liabilities
$28,330K
Other long-term
liabilities
$16,120K
Common stock, 0.001 par
value 400,000,000...
$245K
Accrued and other
current liabilities
$23,397K
Accounts payable
$4,933K
Back
Back
Balance Sheet
source: myfinsight.com
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)